Novartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billion

Thursday, July 5, 2018 - 18:22 in Health & Medicine

AveXis is developing therapies for genetic diseases of the nervous system, including spinal muscular atrophy

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net